In 2022, South Korean pharmaceutical company Yuhan derived around 236.2 billion South Korean won in sales revenue from non-prescription over-the-counter (OTC) drugs. This represents an increase from the previous year.
Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2023
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Colombia: pharmaceutical establishments 2014-2018
- Premium Statistic Industrial production index of basic pharmaceuticals manufacturing in Italy 2020-2023
About the region
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Yuhan-Kimberly's net profit 2016-2019
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue distribution Yuhan 2022, by sector
Selected statistics
10
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Italy: pharmaceutical marketing channels according to GPs
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2023
- Basic Statistic Number of pharmaceutical preparation enterprises in Norway 2016-2022
- Premium Statistic Chemicals and pharma consumption in Russia 2021, by segment
- Premium Statistic Employment in pharma industry in Colombia 2014-2020
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic Industry turnover for leading pharmaceuticals German 2017
- Premium Statistic Salaries among U.S. pharmaceutical sales representatives 2016-2018
Related statistics
10
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
Yuhan. (March 15, 2023). Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won) [Graph]. In Statista. Retrieved May 09, 2024, from https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/
Yuhan. "Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won)." Chart. March 15, 2023. Statista. Accessed May 09, 2024. https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/
Yuhan. (2023). Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won). Statista. Statista Inc.. Accessed: May 09, 2024. https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/
Yuhan. "Sales Revenue of Yuhan Co., Ltd. from Non-prescription (Otc) Drugs from 2016 to 2022 (in Billion South Korean Won)." Statista, Statista Inc., 15 Mar 2023, https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/
Yuhan, Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won) Statista, https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/ (last visited May 09, 2024)
Sales revenue of Yuhan Co., Ltd. from non-prescription (OTC) drugs from 2016 to 2022 (in billion South Korean won) [Graph], Yuhan, March 15, 2023. [Online]. Available: https://www.statista.com/statistics/975548/yuhan-sales-revenue-non-prescription-drugs/